Mindray Medical International (NYSE: MR) is one of 78 publicly-traded companies in the “Advanced Medical Equipment & Technology” industry, but how does it compare to its rivals? We will compare Mindray Medical International to related companies based on the strength of its valuation, earnings, dividends, profitability, institutional ownership, risk and analyst recommendations.

Institutional & Insider Ownership

50.7% of shares of all “Advanced Medical Equipment & Technology” companies are owned by institutional investors. 18.3% of shares of all “Advanced Medical Equipment & Technology” companies are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.


This table compares Mindray Medical International and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Mindray Medical International 15.93% 12.70% 8.37%
Mindray Medical International Competitors -147.32% -22.28% -7.74%

Valuation and Earnings

This table compares Mindray Medical International and its rivals revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Mindray Medical International N/A N/A 18.75
Mindray Medical International Competitors $2.14 billion $229.91 million -30.84

Mindray Medical International’s rivals have higher revenue and earnings than Mindray Medical International. Mindray Medical International is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Analyst Recommendations

This is a summary of current ratings for Mindray Medical International and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mindray Medical International 0 0 0 0 N/A
Mindray Medical International Competitors 266 1876 3363 108 2.59

As a group, “Advanced Medical Equipment & Technology” companies have a potential downside of 10.74%. Given Mindray Medical International’s rivals higher possible upside, analysts clearly believe Mindray Medical International has less favorable growth aspects than its rivals.


Mindray Medical International pays an annual dividend of $0.36 per share and has a dividend yield of 1.3%. Mindray Medical International pays out 24.2% of its earnings in the form of a dividend. As a group, “Advanced Medical Equipment & Technology” companies pay a dividend yield of 0.9% and pay out 27.4% of their earnings in the form of a dividend. Mindray Medical International is clearly a better dividend stock than its rivals, given its higher yield and lower payout ratio.


Mindray Medical International beats its rivals on 5 of the 9 factors compared.

Mindray Medical International Company Profile

Mindray Medical International Limited is a developer, manufacturer and marketer of medical devices across the world. The Company operates in three segments: patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. Its patient monitoring devices track the physiological parameters of patients, such as heart rate, blood pressure, respiration and temperature. It offers patient monitoring devices that are suitable for adult, pediatric and neonatal patients and are used principally in hospital intensive care units, operating rooms and emergency rooms. Its life support products provide operation room or intensive care unit solutions for the end users in the operating room. Its in-vitro diagnostic products provide data and analysis on blood, urine and other bodily fluid samples for clinical diagnosis and treatment. Its medical imaging systems segment includes ultrasound systems, digital radiography systems and a magnetic resonance imaging system.

Receive News & Ratings for Mindray Medical International Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mindray Medical International Ltd and related companies with MarketBeat.com's FREE daily email newsletter.